Encompass Health Corporation (EHC)

NYSE: EHC · Real-Time Price · USD

141.03

+6.24 (4.63%)

At close: Nov 4, 2026, 4:00 PM EST

141.05

+0.02 (0.01%)

Pre-market: Nov 5, 2026, 4:48 AM EST

Encompass Health Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	13,838	10,679	9,304	6,688	5,968	6,493
Market Cap Growth	18.49%	14.78%	39.12%	12.06%	-8.08%	-21.03%
Enterprise Value	16,566	14,105	12,722	10,143	9,391	10,306
Last Close Price	141.03	105.36	91.09	65.45	58.12	49.64

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	22.02	18.91	20.54	19.13	22.12	15.82
Forward PE	21.05	18.91	20.09	18.12	18.95	14.99
PS Ratio	2.18	1.80	1.73	1.39	1.37	1.62
PB Ratio	5.17	3.26	3.27	2.91	3.21	2.71
P/TBV Ratio	13.10	13.15	19.18	76.00	-	12.59
P/FCF Ratio	30.27	24.32	25.82	24.98	49.04	38.17
P/OCF Ratio	10.61	9.08	9.28	7.86	8.46	9.07
PEG Ratio	1.72	1.30	1.14	1.34	1.52	0.72

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	2.61	2.38	2.37	2.11	2.16	2.57
EV/EBITDA Ratio	10.89	10.21	10.83	10.09	10.75	11.73
EV/EBIT Ratio	14.23	13.39	14.54	13.86	14.90	15.63
EV/FCF Ratio	36.23	32.12	35.31	37.89	77.16	60.59

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.79	0.83	0.95	1.28	1.61	1.45
Debt / EBITDA Ratio	1.78	1.89	2.21	2.77	3.23	3.72
Debt / FCF Ratio	6.13	6.18	7.53	10.96	24.59	20.47
Net Debt / Equity Ratio	0.77	0.81	0.92	1.25	1.60	1.43
Net Debt / EBITDA Ratio	1.79	1.91	2.24	2.85	3.40	3.90
Net Debt / FCF Ratio	5.97	6.02	7.30	10.70	24.41	20.18
Asset Turnover	0.88	0.87	0.85	0.82	0.70	0.60
Quick Ratio	0.85	0.83	0.81	1.04	0.97	0.76
Current Ratio	1.09	1.08	1.06	1.28	1.25	1.23
Return on Equity (ROE)	25.11%	24.82%	23.29%	22.84%	16.46%	18.32%
Return on Assets (ROA)	10.06%	9.66%	8.65%	7.79%	6.30%	6.19%
Return on Invested Capital (ROIC)	14.79%	14.74%	13.15%	11.46%	9.20%	9.44%
Return on Capital Employed (ROCE)	17.50%	16.80%	15.40%	13.40%	12.50%	10.80%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 4, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	4.54%	5.30%	4.90%	5.26%	4.54%	6.35%
FCF Yield	3.30%	4.11%	3.87%	4.00%	2.04%	2.62%
Dividend Yield	0.60%	0.67%	0.69%	0.90%	1.44%	1.72%
Payout Ratio	13.12%	12.56%	13.78%	17.16%	36.53%	27.22%
Buyback Yield / Dilution	1.61%	-0.60%	-0.89%	-0.90%	-0.20%	-0.40%
Total Shareholder Return	2.21%	0.07%	-0.19%	0.00%	1.24%	1.31%

SEC Filings: 10-K · 10-Q